Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Thromb Res. 2020 May 11;192:40–51. doi: 10.1016/j.thromres.2020.05.008

Figure 2 -.

Figure 2 -

This diagram demonstrates our current understanding of the effects of estrogen on hemostasis & thrombosis. 1) The exact effect of estrogen on platelet activation and aggregation remains unclear, with conflicting reports in the literature showing altered platelet behavior. Estrogen is known to increase VWF levels which plays a central role in platelet adhesion and activation. 2) Estrogen leads to increased thrombin generation and fibrin clot formation by increasing the levels of variable coagulation proteins (green arrowheads) and decreasing the levels of anticoagulant proteins (red arrowheads). 3) Conversely, estrogen has also been shown to be associated with increased fibrinolysis due to decreased PAI-1 levels, which does not seem to balance out the increase in coagulation. Thus the net effect overall, has been shown to be prothrombotic.

aPC = activated Protein C

AT = anti-thrombin

PAI-1 = plasminogen activator inhibitor 1

PL = phospholipid

TM = thrombomodulin

tPA = tissue plasminogen activator

VWF = von Willebrand Factor

* In different studies, estrogen has been shown to increase Protein C antigen levels but also increase Protein C resistance